SUBSCRIBE
SUBSCRIBE
News   Drug Development

Pazopanib Shrinks Lung Cancers Before Surgery, US Researchers Report.

September 16, 2008 | 
1 min read

EurekAlert! -- Pazopanib, a new oral angiogenesis inhibitor, has demonstrated interesting activity in difficult to treat non-small-cell lung cancer, US researchers report.

Clinical research Phase II
MORE ON THIS TOPIC
Sanofi's Distribution Center in Quebec, Canada
Multiple sclerosis
Sanofi, Denali Abandon Mid-Stage Multiple Sclerosis Study on Disappointing Data
October 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Drug Development
How AI Could Ease Tension in Clinical Trials
October 10, 2024
 · 
1 min read
 · 
Lori Ellis
Sign in front of Pfizer in Quebec, Canada
Prostate cancer
Pfizer Phase III Prostate Cancer Win Builds Case for Broader Label for Talzenna-Xtandi Combo
October 10, 2024
 · 
2 min read
 · 
Tristan Manalac
Concept art of a gene therapy showing a syringe injecting into a 3D DNA helix
Gene therapy
7 Children Receiving Bluebird’s Gene Therapy Developed Blood Cancers: Study
October 10, 2024
 · 
2 min read
 · 
Tristan Manalac